University of Cambridge

University of Cambridge

University of Cambridge

Overview
Date Founded

1990

Headquarters

The Old Schools,Trinity Lane,Cambridge, Cambridgeshire CB2 1TN

Charitable Causes

Higher Education & Universities
Education Research & Support

Employees (Worldwide)

10K - 1M

Company Description

The University of Cambridge (informally known as Cambridge University or Cambridge) is a public research university located in Cambridge, United Kingdom. It is the second-oldest university in the English-speaking world (after the University of Oxford), and the seventh-oldest in the world.

Executives & Employees

Chief Investment Officer

Chair of Cancer Medicine, Department of Oncology

Head, Department of Veterinary Medicine

Head, Accelerate Program for Scientific Discovery

Head of the Geotechnical Group, Civil & Environmental Engineering

Head of Talent Management & Human Resources, Development & Alumni Relations Office

Professor, Neurology & Head of the Department of Clinical Neurosciences

Head, Department of Public Health & Primary Care

Head of Private Equity

Head, Department of Psychology

Board of Directors

Senior Adviser at Morgan Stanley International Ltd.

Founder & Chairman at Aravis AG

Co-Founder at Psynova Neurotech Ltd.

Founder at Dill Faulkes Educational Trust

Co-Founder at Psynova Neurotech Ltd.

Director at University of Cambridge

Director at University of Cambridge

Former Group Chief Executive Officer at Dar Al-Maal Al-Islami Trust

Distinguished Alumni
Jane Fraser is now Director, President & Chief Executive Officer at Citigroup, Inc.
Michael S. Chae is now Chief Financial Officer at The Blackstone Group, Inc.
Paths to University of Cambridge
Potential Connections via
Relationship Science
You
University of Cambridge
Recent Transactions
Details Hidden

University of Cambridge, Cambridge University Press purchase University of Durham /CEM from University of Durham

Details Hidden

Frontier IP Group Plc purchases Tarsis Technology Ltd. from University of Cambridge

Details Hidden

University of Cambridge, Cambridge University Press purchase Foundation Books Pvt Ltd. resulting in a new company Cambridge University Press India Pvt Ltd.

Advisors & Consultants
Legal Advisor

Partner, Head of Capital Markets, London at Clifford Chance LLP

Advisor

Advisory at Qatium

Legal Advisor

Partner at Clifford Chance LLP

Clients

New Oriental Education & Technology Group, Inc. is a holding company, which engages in the provision of private educational services. It operates through the following segments: K-12 AST, Test preparation, and Other Courses, Primary and Secondary School Education, Online Education, Content Development and Distribution, Pre-School Education, Overseas Study Consulting Services, and Study Tours. The company was founded by Min Hong Yu and Yong Qiang Qian on November 16, 1993 and is headquartered in Beijing, China.

Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases. The firm's progenitor cell activation approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapies. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in a solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY.

Non-Profit Donations & Grants Received
$1,000
12/31/2017
$5,000
12/31/2016
$100K
12/31/2015
Investments
Details Hidden

NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom.

Details Hidden

CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom.

Details Hidden

Akubio Ltd. develops acoustic biosensor instruments. Its products are used in protein research and drug development. The company's technology based on quartz resonators delivers molecular identification and measurement of interactions in complex samples. Akubio was founded by Matthew A. Cooper in August 2001 and is headquartered in Cambridge, UK

Suppliers
Harvard Bioscience, Inc. Industrial Machinery & Manufacturing | Holliston, MA

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

ATA Creativity Global Other Business & Consulting Services | Beijing, China

ATA Creativity Global engages in the provision of computer-based testing services. It serves professional licensure and certification tests in various industries, which include IT services, banking, teaching, and insurance. The company was founded by Kevin Xiaofeng Ma and Walter Lin Wang in 1999 and is headquartered in Beijing, China.

Cambridge Cognition Holdings Plc Hospitals & Patient Services | Bottisham, United Kingdom

Cambridge Cognition Holdings Plc is a neuroscience digital health company, which engages in the development of digital health products to better understand, detect, and treat conditions affecting brain health. It operates through the following segments: Software, Services, and Hardware. The company's products include drug development, cognitive research, and healthcare technology. The company was founded on September 12, 2012 and is headquartered in Cambridge, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by University of Cambridge. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of University of Cambridge's profile does not indicate a business or promotional relationship of any kind between RelSci and University of Cambridge.